EP3601283
Samrunnið imídasó-píperidín-JAK-hindra-efnasamband
:
EP Einkaleyfi fallið úr gildi:
30.4.2018:
29.12.2021:
18724754.9
:
24.2.2022:
15.3.2022
:
29.4.2038:
29.4.2024
:
FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND
30.4.2018
29.12.2021
24.2.2022
15.3.2022
29.4.2024
:
Theravance Biopharma R&D IP, LLC:
901 Gateway Boulevard, South San Francisco, CA 94080, US
:
FATHEREE, Paul R.:
San Francisco, California 94107, US
:
JIANG, Lan:
Foster City, California 94404, US
:
MCKINNELL, Robert Murray:
Millbrae, California 94030, US
:
THALLADI, Venkat R.:
Foster City, California 94404, US
:
ZHANG, Hao:
Foster City, California 94404, US
:
DABROS, Marta:
Foster City, California 94404, US
:
NZEREM, Jerry:
South San Francisco, California 94080, US
:
BENJAMIN, Noah:
San Francisco, California 94122, US
:
KLEINSCHEK, Melanie A.:
South San Francisco, California 94080, US
:
CRATER, Glenn D.:
Raleigh, North Carolina 27612, US
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201762492574 P:
1.5.2017:
US
:
US2018030148:
30.4.2018
:
C07D 471/04, A61K 31/437, A61P 11/00, A61P 17/00, A61P 27/02
: 5
: 31.3.2022
: 29.4.2023
: Patice ehf.
: 6
: 31.3.2023
: 29.4.2024
: Árnason Faktor ehf.